1 |
Brożek JL, Bousquet J, Agache I, et al. Allergic rhinitis and its impact on Asthma (ARIA) guidelines-2016 revision[J]. J Allergy Clin Immunol, 2017, 140(4): 950-958.
|
2 |
Dykewicz MS, Wallace DV, Baroody F, et al. Treatment of seasonal allergic rhinitis: an evidence-based focused 2017 guideline update[J]. Ann Allergy Asthma Immunol, 2017, 119(6): 489-511.
|
3 |
Blaiss MS, Hammerby E, Robinson S, et al. The burden of allergic rhinitis and allergic rhinoconjunctivitis on adolescents: a literature review[J]. Ann Allergy Asthma Immunol, 2018, 121(1): 43-52.
|
4 |
Meltzer EO, Blaiss MS, Derebery MJ, et al. Burden of allergic rhinitis: results from the Pediatric Allergies in America survey[J]. Allergy Clin Immunol, 2009, 124(3 Suppl): S43-70.
|
5 |
Asher MI, Montefort S, Björkstén B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys[J]. Lancet, 2006, 368(9537): 733-743.
|
6 |
Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: an updated practice parameter[J]. J Allergy Clin Immunol, 2008, 122(2 Suppl): S1-84.
|
7 |
Smith HE, Hogger C, Lallemant C, et al. Is struc-tured allergy history sufficient when assessing patients with asthma and rhinitis in general practice[J]? J Allergy Clin Immunol, 2009, 123(3): 646-650.
|
8 |
Vidal C, Gude F, Boquete O, et al. Evaluation of the phadiatop test in the diagnosis of allergic sensitization in a general adult population[J]. J Investig Allergol Clin Immunol, 2005, 15(2): 124-130.
|
9 |
Eriksson NE. Allergy screening with Phadiatop and CAP Phadiatop in combination with a questionnaire in adults with asthma and rhinitis[J]. Allergy, 1990, 45(4): 285-292.
|
10 |
O'sullivan JA, Bochner BS. Eosinophils and eosinophil-associated diseases: an update[J]. J Allergy Clin Immunol, 2018, 141(2): 505-517.
|
11 |
Huang L, Gebreselassie NG, Gagliardo LF, et al. Eosinophil-derived IL-10 supports chronic nematode infection[J]. J Immunol, 2014, 193: 4178-4187.
|
12 |
Togias A, Naclerio RM, Proud D, et al. Studies on the allergic and nonallergic nasal inflammation[J]. J Allergy Clin Immunol, 1988, 81(5 Pt 1): 782-790.
|
13 |
Rondón C, Campo P, Togias A, et al. Local allergic rhinitis: concept, pathophysiology, and management[J]. J Allergy Clin Immunol, 2012, 129(6): 1460-1467.
|
14 |
Chiarotto A, Maxwell LJ, Ostelo RW, et al. Measurement properties of visual analogue scale, numeric rating scale, and pain severity subscale of the brief pain inventory in patients with low back pain: a systematic review[J]. J Pain, 2019, 20(3): 245-263.
|
15 |
Heller GZ, Manuguerra M, Chow R. How to analyze the Visual Analogue Scale: Myths, truths and clinical relevance[J]. Scand J Pain, 2016, 13: 67-75.
|
16 |
Valero A, Ferrer M, Sastre J, et al. A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic Rhinitis and its Impact on Asthma severity items[J]. J Allergy Clin Immunol, 2007, 120(2): 359-365.
|
17 |
Matucci A, Vultaggio A, Maggi E, et al. Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question[J]? Respir Res, 2018, 19(1): 113.
|
18 |
Yenigun A, Sezen S, Calim OF, et al. Evaluation of the eosinophil-to-lymphocyte ratio in pediatric patients with allergic rhinitis[J]. Am J Rhinol Allergy, 2016, 30(2): e21-e25.
|
19 |
Rosenberg HF, Phipps S, Foster PS. Eosinophil trafficking in allergy and asthma[J]. J Allergy Clin Immunol, 2007, 119(6): 1303-1312.
|
20 |
Linden M, Svensson C, Andersson M, et al. Circulating eosinophil/basophil progenitors and nasal mucosal cytokines in seasonal allergic rhinitis[J]. Allergy. 1999, 54(3): 212-219.
|
21 |
Roethlisberger S, Karoui O, Mapelli D, et al. Novel nanofluidic ige assay versus a reference method: a real-world comparison[J]. Int Arch Allergy Immunol, 2019, 180(1): 28-36.
|
22 |
Sharma M, Khaitan T, Raman S, et al. Determination of serum IgE and eosinophils as a diagnostic indicator in allergic rhinitis[J]. Indian J Otolaryngol Head Neck Surg, 2019, 71: 1957-1961.
|
23 |
姜翠菊. 变应性鼻炎鼻腔灌洗液和血清中嗜酸粒细胞阳离子蛋白的关系[J]. 新疆医学, 2019, 49(04): 361-363.
|
24 |
罗鸿, 陶泽璋, 孔维佳. 变应性鼻炎造血机制的调控与嗜酸性粒细胞的产生[J]. 国际耳鼻咽喉头颈外科杂志, 2009, 33(2): 67-70.
|
25 |
Fulkerson PC, Rothenberg ME. Targeting eosinophils in allergy, inflammation and beyond[J]. Nat Rev Drug Discov, 2013, 12(2): 117-129.
|
26 |
Bengtsson U, Knutson TW, Knutson L, et al. Eosinophil cationic protein and histamine after intestinal challenge in patients with cow's milk intolerance[J]. J Allergy Clin Immunol, 1997, 100(2): 216-221.
|
27 |
Mould AW, Matthaei KI, Young IG, et al. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice[J]. J Clin Invest, 1997, 99(5): 1064-1071.
|
28 |
Costa GG, Silva RM, Franco-Penteado CF, et al. Interactions between eotaxin and interleukin-5 in the chemotaxis of primed and non-primed human eosinophils[J]. Eur J Pharmacol, 2007, 566(1-3): 200-205.
|
29 |
Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma[J]. N Engl J Med, 2009, 360(10): 973-984.
|
30 |
Carlson M, Peterson C, Venge P, et al. The influence of IL-3, IL-5, and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation[J]. Allergy, 1993, 48(6): 437-442.
|